Targeting Nrf3-Pitx2-ROS axis represents a promising therapeutic strategy for myocardial infarction

Min Zhang , Hui He , Zhen He , Jin Zou , Xiaobo Hu

MedScience ›› 2026, Vol. 20 ›› Issue (1) : 194 -197.

PDF (512KB)
MedScience ›› 2026, Vol. 20 ›› Issue (1) :194 -197. DOI: 10.1007/s11684-025-1194-7
COMMENT
Targeting Nrf3-Pitx2-ROS axis represents a promising therapeutic strategy for myocardial infarction
Author information +
History +
PDF (512KB)

Cite this article

Download citation ▾
Min Zhang, Hui He, Zhen He, Jin Zou, Xiaobo Hu. Targeting Nrf3-Pitx2-ROS axis represents a promising therapeutic strategy for myocardial infarction. MedScience, 2026, 20(1): 194-197 DOI:10.1007/s11684-025-1194-7

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Bugger H , Pfeil K . Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol Basis Dis 2020; 1866(7): 165768

[2]

Kobayashi A , Ito E , Toki T , Kogame K , Takahashi S , Igarashi K , Hayashi N , Yamamoto M . Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J Biol Chem 1999; 274(10): 6443–6452

[3]

Zhang Y , Chen X , Wang M , Zhu Y , Shi W , Li C , Zhang Z , Taniguchi H , Ao P . Nrf1 acts as a highly-conserved determinon for maintaining robust redox homeostasis in the eco-evo-devo process of life histories. Cell Stress 2025; 9: 65–142

[4]

Fiori E , Davinelli S , Ferrera A , Medoro A , Barsali C , Battistoni A , Volterrani M , Volpe M , Saso L , Rubattu S . The emerging role of Nrf2 in heart failure: from cardioprotection to therapeutic approaches. ESC Heart Fail 2025; 12(6): 4000–4020

[5]

Xiao Q , Pepe AE , Wang G , Luo Z , Zhang L , Zeng L , Zhang Z , Hu Y , Ye S , Xu Q . Nrf3-Pla2g7 interaction plays an essential role in smooth muscle differentiation from stem cells. Arterioscler Thromb Vasc Biol 2012; 32(3): 730–744

[6]

Zheng C , Pan Y , Lin B , Li J , Chen Q , Zheng Z . NRF3 suppresses the metastasis of triple-negative breast cancer cells by inhibiting ERK activation in a ROS-dependent manner. Histol Histopathol 2025; 40(1): 123–131

[7]

Chen Q , Zheng A , Xu X , Shi Z , Yang M , Sun S , Wang L , Wang Y , Zhao H , Xiao Q , Zhang L . Nrf3-mediated mitochondrial superoxide promotes cardiomyocyte apoptosis and impairs cardiac functions by suppressing Pitx2. Circulation 2025; 151(14): 1024–1046

[8]

Subati T , Kim K , Yang Z , Murphy MB , Van Amburg JC , Christopher IL , Dougherty OP , Woodall KK , Smart CD , Johnson JE , Fogo AB , Amarnath V , Agrawal V , Barnett JV , Saffitz JE , Murray KT . Oxidative stress causes mitochondrial and electrophysiologic dysfunction to promote atrial fibrillation in Pitx2+/− mice. Circ Arrhythm Electrophysiol 2025; 18(3): e013199

[9]

Tao G , Kahr PC , Morikawa Y , Zhang M , Rahmani M , Heallen TR , Li L , Sun Z , Olson EN , Amendt BA , Martin JF . Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury. Nature 2016; 534(7605): 119–123

[10]

Reyat JS , Sommerfeld LC , O’Reilly M , Roth Cardoso V , Thiemann E , Khan AO , O’Shea C , Harder S , Müller C , Barlow J , Stapley RJ , Chua W , Kabir SN , Grech O , Hummel O , Hübner N , Kääb S , Mont L , Hatem SN , Winters J , Zeemering S , Morgan NV , Rayes J , Gehmlich K , Stoll M , Brand T , Schweizer M , Piasecki A , Schotten U , Gkoutos GV , Lorenz K , Cuello F , Kirchhof P , Fabritz L . PITX2 deficiency leads to atrial mitochondrial dysfunction. Cardiovasc Res 2024; 120(15): 1907–1923

[11]

Li L , Tao G , Hill MC , Zhang M , Morikawa Y , Martin JF . Pitx2 maintains mitochondrial function during regeneration to prevent myocardial fat deposition. Development 2018; 145(18): dev168609

[12]

Kao YH , Chen YC , Chung CC , Lien GS , Chen SA , Kuo CC , Chen YJ . Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation. Clin Exp Pharmacol Physiol 2013; 40(6): 379–384

[13]

Dubois-Deruy E , Peugnet V , Turkieh A , Pinet F . Oxidative stress in cardiovascular diseases. Antioxidants 2020; 9(9): 864

[14]

Murry CE , Jennings RB , Reimer KA . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74(5): 1124–1136

[15]

Hausenloy DJ , Barrabes JA , Bøtker HE , Davidson SM , Di Lisa F , Downey J , Engstrom T , Ferdinandy P , Carbrera-Fuentes HA , Heusch G , Ibanez B , Iliodromitis EK , Inserte J , Jennings R , Kalia N , Kharbanda R , Lecour S , Marber M , Miura T , Ovize M , Perez-Pinzon MA , Piper HM , Przyklenk K , Schmidt MR , Redington A , Ruiz-Meana M , Vilahur G , Vinten-Johansen J , Yellon DM , Garcia-Dorado D . Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol 2016; 111(6): 70

[16]

Bhatt DL , Lopes RD , Harrington RA . Diagnosis and treatment of acute coronary syndromes: a review. JAMA 2022; 327(7): 662–675

RIGHTS & PERMISSIONS

Higher Education Press

PDF (512KB)

751

Accesses

0

Citation

Detail

Sections
Recommended

/